Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events
CAC Helps ID CVD Risk in Women Receiving RT for Breast Cancer
Higher CAC score calculated from radiotherapy-planning CT scan linked to increased risk for CVD
Individuals With Blood Group O Have Lower Risk for COVID-19
And more COVID-19 patients with blood group A or AB require mechanical ventilation, CRRT
Surgeon General Issues Call to Action for Hypertension Control
Three specific goals can drive change in hypertension control in the United States
Immune Responses Long-Lasting After Serious COVID-19
IgG levels remain elevated for four months in patients with symptoms lasting for 14 days
COVID-19 Antibody Treatment Study Paused
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused 'out of an abundance of caution'
FDA Warns Companies About Illegal Sales of Dietary Supplements
The supplements contain cesium chloride, but no cesium chloride-containing products are FDA-approved
Alcohol Abstinence Increased Among Young Adults From 2002 to 2018
However, increase seen in marijuana use, co-use of alcohol and marijuana
Black Race Tied to COVID-19 Admissions, but Not Deaths
In-hospital mortality higher for Asian patients, despite lower risk for hospital admission
Maternal Epidural During Birth Linked to Later Autism in Kids
Autism risk seems to increase with longer duration of epidural exposure
